News
New Drug to Control Pain Related to Cancer Treatment Originally Developed at Stony Brook Gets FDA Clearance (read more)
Artelo Biosciences Receives FDA Clearance of its IND Application for ART26.12, a Selective Fatty Acid Binding Protein 5 Inhibitor (Read more )
ICB&DD Welcomes New Member: Dr. Ivet Bahar
Dr. Ivet Bahar, Professor, Department of Biochemistry and Cell Biology, Louis and Beatrice Laufer
Endowed Chair
Director, Laufer Center for Physical and Quantitative Biology (read more)
Dr. Hiroaki Suga Receives The Ojima Distinguished Lectureship Award in Chemistry
Dr. Hiroaki Suga gave a lecture at The Ojima Distinguished Lectureship Award in Chemistry
on April 26 at the Wang Center, SBU. (Read more)
Advancing Technology to Improve the Therapeutic Effect of Radionuclide Therapy for Cancer
Dr, Jacob Houghton, ICB&DD Member and Assistant Professor in the Department of Radiology
in the Renaissance School of Medicine (RSOM), and researcher in the Stony Brook Cancer
Center, conducts research on targeted radionuclide therapy for diagnosing and treating
cancer. (Read more)
ICB&DD Welcomes New Members: Drs. Anissa Abi-Dargham, Stuti Sharma and Markus Riessland
Dr. Anissa Abi-Dargham, Distinguished Professor and The Lourie Endowed Chair, Department of Psychiatry and Behavioral Health, Stony Brook Renaissance School
of Medicine
Dr. Stuti Sharma, Assistant Professor, Department of Biochemistry and Cell Biology, Stony Brook Renaissance
School of Medicine
Dr. Markus Riessland , Assistant Professor, Department of Neurobiology and Behavior, Stony Brook Renaissance
School of Medicine
ICB&DD 17th Annual Symposium "Frontiers in Chemical Biology and Drug Discovery" at the SAC (read more)
From SBU news Drug Discoveries, Students Research Showcased at ICB&DD Symposium
ICB&DD welcomes New Members: Drs. Matthew Parker and Jeffrey Lipshultz
Dr. Matthew Parker, Assistant Professor, Department of Psychiatry and Behavioral Health.
Stony Brook Renaissance School of Medicine
Dr. Jeffrey Lipshultz, Assistant Professor, Department of Chemistry.
(read more)
Congratulations to ICB&DD Member,Dr. Jingfang Ju, Professor in the Department of Pathology for being on the cover of the International
Journal of Oncology (Int. J. Oncol.) for the month of July 2023. Int. J. Oncol. is an international journal devoted to oncology research and cancer treatment.
(See more)
Dr. John Hartwig Receives The Ojima Distinguished Lectureship Award in Chemistry
Dr. John Hartwig gave a lecture at the Ojima Distinguished Lectureship Award in Chemistry
on May 5 at the Wang Center, SBU.
Message from the Director
Dr. Iwao Ojima, Distinguished Professor and Director, ICB&DD
Welcome to the Institute of Chemical Biology & Drug Discovery
The primary objective of ICB&DD is to establish a world-class “Center of Excellence” in chemical biology and drug discovery at Stony Brook. The rapid and impressive advancement of chemical biology in the last decades clearly demonstrated that solutions for vast majority of medical problems rely on the understanding of the molecular basis of diseases, therapeutic targets, drug actions, and drug resistance. ICB&DD promotes highly productive interdisciplinary and multidisciplinary research bridging the West, East and South campuses as well as Brookhaven National Laboratory to attack major and significant biomedical problems to find solutions including the discovery of novel therapeutic drugs. ICB&DD significantly contributes to the advancement of a truly comprehensive biomedical research enterprise from molecular science to clinic at Stony Brook.
ICB&DD Events
|
ICB&DD 2023 SYMPOSIUM  Poster Session
|
